3Q11 Victrelis sales were a scant $31M, not even 10% of the Incivek sales of $420M during the same period: http://finance.yahoo.com/news/Merck-Announces-Third-Quarter-bw-3116886851.html?x=0&.v=1 Ouch for MRK.